11-83273851-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021825.5(CCDC90B):c.482G>A(p.Arg161Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000193 in 1,608,260 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021825.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC90B | NM_021825.5 | c.482G>A | p.Arg161Gln | missense_variant | 6/9 | ENST00000529689.6 | NP_068597.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC90B | ENST00000529689.6 | c.482G>A | p.Arg161Gln | missense_variant | 6/9 | 1 | NM_021825.5 | ENSP00000434724.1 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151886Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000614 AC: 15AN: 244164Hom.: 0 AF XY: 0.0000530 AC XY: 7AN XY: 131966
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1456256Hom.: 0 Cov.: 31 AF XY: 0.0000166 AC XY: 12AN XY: 724086
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152004Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74306
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 13, 2023 | The c.482G>A (p.R161Q) alteration is located in exon 6 (coding exon 6) of the CCDC90B gene. This alteration results from a G to A substitution at nucleotide position 482, causing the arginine (R) at amino acid position 161 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at